Astera Labs Inc (ALAB) concluded trading on Wednesday at a closing price of $130.77, with 3.68 million shares of worth about $481.33 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 129.91% during that period and on January 08, 2025 the price saw a loss of about -2.12%. Currently the company’s common shares owned by public are about 158.56M shares, out of which, 116.41M shares are available for trading.
Stock saw a price change of -1.27% in past 5 days and over the past one month there was a price change of 8.61%. Over the period of past 52 weeks, stock dropped to lowest price of $36.22 but also hit the highest price of $147.39 during that period. The average intraday trading volume for Astera Labs Inc shares is 5.03 million. The stock is currently trading -1.33% below its 20-day simple moving average (SMA20), while that difference is up 18.54% for SMA50 and it goes to 81.81% higher than SMA200.
Astera Labs Inc (NASDAQ: ALAB) currently have 158.56M outstanding shares and institutions hold larger chunk of about 46.34% of that.
The stock has a current market capitalization of $20.74B. It has posted earnings per share of -$0.60 in the same period. It has Quick Ratio of 10.46 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ALAB, volatility over the week remained 6.76% while standing at 6.21% over the month.
Stock’s fiscal year EPS is expected to rise by 700.71% while it is estimated to increase by 62.07% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Northland Capital on January 02, 2025 offering a Market perform rating for the stock and assigned a target price of $120 to it. Coverage by Citigroup stated Astera Labs Inc (ALAB) stock as a Buy in their note to investors on November 18, 2024, suggesting a price target of $120 for the stock. On September 04, 2024, Morgan Stanley Upgrade their recommendations, while on April 16, 2024, Evercore ISI Initiated their ratings for the stock with a price target of $100. Stock get a Buy rating from Stifel on April 15, 2024.
